nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2C9—brain cancer	0.606	1	CbGaD
Carbinoxamine—CYP2D6—Lomustine—brain cancer	0.0718	0.239	CbGbCtD
Carbinoxamine—CYP2D6—Hydroxyurea—brain cancer	0.0544	0.181	CbGbCtD
Carbinoxamine—CYP3A4—Temozolomide—brain cancer	0.0537	0.179	CbGbCtD
Carbinoxamine—CYP3A4—Lomustine—brain cancer	0.0457	0.152	CbGbCtD
Carbinoxamine—CYP2E1—Etoposide—brain cancer	0.0364	0.121	CbGbCtD
Carbinoxamine—CYP2C8—Etoposide—brain cancer	0.0272	0.0906	CbGbCtD
Carbinoxamine—CYP3A4—Etoposide—brain cancer	0.011	0.0367	CbGbCtD
Carbinoxamine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00175	0.0517	CbGpPWpGaD
Carbinoxamine—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00157	0.0464	CbGpPWpGaD
Carbinoxamine—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00144	0.0425	CbGpPWpGaD
Carbinoxamine—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00143	0.0423	CbGpPWpGaD
Carbinoxamine—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.00141	0.0416	CbGpPWpGaD
Carbinoxamine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.0014	0.0414	CbGpPWpGaD
Carbinoxamine—Photosensitivity—Procarbazine—brain cancer	0.00131	0.0221	CcSEcCtD
Carbinoxamine—Haemolytic anaemia—Procarbazine—brain cancer	0.00128	0.0215	CcSEcCtD
Carbinoxamine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00128	0.0377	CbGpPWpGaD
Carbinoxamine—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00122	0.036	CbGpPWpGaD
Carbinoxamine—Diplopia—Procarbazine—brain cancer	0.00115	0.0194	CcSEcCtD
Carbinoxamine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00109	0.0321	CbGpPWpGaD
Carbinoxamine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000999	0.0295	CbGpPWpGaD
Carbinoxamine—Sweating increased—Procarbazine—brain cancer	0.000971	0.0164	CcSEcCtD
Carbinoxamine—Pollakiuria—Procarbazine—brain cancer	0.00092	0.0155	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Procarbazine—brain cancer	0.000909	0.0153	CcSEcCtD
Carbinoxamine—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000891	0.0264	CbGpPWpGaD
Carbinoxamine—Drowsiness—Procarbazine—brain cancer	0.000888	0.015	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Lomustine—brain cancer	0.000874	0.0147	CcSEcCtD
Carbinoxamine—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.000873	0.0258	CbGpPWpGaD
Carbinoxamine—Neuropathy peripheral—Procarbazine—brain cancer	0.000871	0.0147	CcSEcCtD
Carbinoxamine—Chest discomfort—Etoposide—brain cancer	0.000868	0.0146	CcSEcCtD
Carbinoxamine—Anorexia—Lomustine—brain cancer	0.000851	0.0143	CcSEcCtD
Carbinoxamine—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00084	0.0248	CbGpPWpGaD
Carbinoxamine—Decreased appetite—Lomustine—brain cancer	0.000776	0.0131	CcSEcCtD
Carbinoxamine—Nasal congestion—Temozolomide—brain cancer	0.000765	0.0129	CcSEcCtD
Carbinoxamine—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000755	0.0223	CbGpPWpGaD
Carbinoxamine—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000726	0.0215	CbGpPWpGaD
Carbinoxamine—Diplopia—Carmustine—brain cancer	0.000721	0.0122	CcSEcCtD
Carbinoxamine—Chills—Procarbazine—brain cancer	0.000716	0.0121	CcSEcCtD
Carbinoxamine—Diplopia—Temozolomide—brain cancer	0.000697	0.0118	CcSEcCtD
Carbinoxamine—Drowsiness—Hydroxyurea—brain cancer	0.000688	0.0116	CcSEcCtD
Carbinoxamine—Tension—Procarbazine—brain cancer	0.000681	0.0115	CcSEcCtD
Carbinoxamine—Nervousness—Procarbazine—brain cancer	0.000674	0.0114	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000674	0.0114	CcSEcCtD
Carbinoxamine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000674	0.0199	CbGpPWpGaD
Carbinoxamine—Tremor—Procarbazine—brain cancer	0.00065	0.011	CcSEcCtD
Carbinoxamine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000648	0.0191	CbGpPWpGaD
Carbinoxamine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000619	0.0183	CbGpPWpGaD
Carbinoxamine—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000612	0.0181	CbGpPWpGaD
Carbinoxamine—Convulsion—Procarbazine—brain cancer	0.000601	0.0101	CcSEcCtD
Carbinoxamine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000596	0.0176	CbGpPWpGaD
Carbinoxamine—Sweating increased—Temozolomide—brain cancer	0.000587	0.0099	CcSEcCtD
Carbinoxamine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000583	0.0172	CbGpPWpGaD
Carbinoxamine—Confusional state—Procarbazine—brain cancer	0.000571	0.00964	CcSEcCtD
Carbinoxamine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000571	0.0169	CbGpPWpGaD
Carbinoxamine—Vomiting—Lomustine—brain cancer	0.000567	0.00957	CcSEcCtD
Carbinoxamine—Pollakiuria—Temozolomide—brain cancer	0.000556	0.00939	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Procarbazine—brain cancer	0.000555	0.00936	CcSEcCtD
Carbinoxamine—Chills—Hydroxyurea—brain cancer	0.000554	0.00934	CcSEcCtD
Carbinoxamine—Tachycardia—Procarbazine—brain cancer	0.000553	0.00933	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Temozolomide—brain cancer	0.00055	0.00927	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Procarbazine—brain cancer	0.000548	0.00924	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Carmustine—brain cancer	0.000545	0.00919	CcSEcCtD
Carbinoxamine—Anorexia—Procarbazine—brain cancer	0.00054	0.00911	CcSEcCtD
Carbinoxamine—Nausea—Lomustine—brain cancer	0.00053	0.00894	CcSEcCtD
Carbinoxamine—Hypotension—Procarbazine—brain cancer	0.000529	0.00893	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Temozolomide—brain cancer	0.000526	0.00888	CcSEcCtD
Carbinoxamine—Insomnia—Procarbazine—brain cancer	0.000512	0.00864	CcSEcCtD
Carbinoxamine—Paraesthesia—Procarbazine—brain cancer	0.000509	0.00858	CcSEcCtD
Carbinoxamine—Somnolence—Procarbazine—brain cancer	0.000504	0.00849	CcSEcCtD
Carbinoxamine—Decreased appetite—Procarbazine—brain cancer	0.000493	0.00831	CcSEcCtD
Carbinoxamine—Fatigue—Procarbazine—brain cancer	0.000488	0.00824	CcSEcCtD
Carbinoxamine—Constipation—Procarbazine—brain cancer	0.000485	0.00817	CcSEcCtD
Carbinoxamine—Sweating increased—Etoposide—brain cancer	0.00047	0.00792	CcSEcCtD
Carbinoxamine—Feeling abnormal—Procarbazine—brain cancer	0.000467	0.00787	CcSEcCtD
Carbinoxamine—Convulsion—Hydroxyurea—brain cancer	0.000466	0.00785	CcSEcCtD
Carbinoxamine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000462	0.0137	CbGpPWpGaD
Carbinoxamine—Urticaria—Procarbazine—brain cancer	0.00045	0.00759	CcSEcCtD
Carbinoxamine—Tinnitus—Temozolomide—brain cancer	0.00045	0.00758	CcSEcCtD
Carbinoxamine—Chills—Temozolomide—brain cancer	0.000433	0.0073	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000429	0.00724	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Etoposide—brain cancer	0.000421	0.00711	CcSEcCtD
Carbinoxamine—Anorexia—Hydroxyurea—brain cancer	0.000418	0.00705	CcSEcCtD
Carbinoxamine—Vision blurred—Carmustine—brain cancer	0.000409	0.0069	CcSEcCtD
Carbinoxamine—Tremor—Carmustine—brain cancer	0.000407	0.00686	CcSEcCtD
Carbinoxamine—Asthenia—Procarbazine—brain cancer	0.000407	0.00686	CcSEcCtD
Carbinoxamine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000405	0.012	CbGpPWpGaD
Carbinoxamine—Agranulocytosis—Etoposide—brain cancer	0.000401	0.00676	CcSEcCtD
Carbinoxamine—Agitation—Carmustine—brain cancer	0.000399	0.00673	CcSEcCtD
Carbinoxamine—Vision blurred—Temozolomide—brain cancer	0.000396	0.00667	CcSEcCtD
Carbinoxamine—Tremor—Temozolomide—brain cancer	0.000393	0.00663	CcSEcCtD
Carbinoxamine—Somnolence—Hydroxyurea—brain cancer	0.00039	0.00657	CcSEcCtD
Carbinoxamine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00039	0.0115	CbGpPWpGaD
Carbinoxamine—Diarrhoea—Procarbazine—brain cancer	0.000388	0.00654	CcSEcCtD
Carbinoxamine—Dyspepsia—Hydroxyurea—brain cancer	0.000386	0.00651	CcSEcCtD
Carbinoxamine—Agitation—Temozolomide—brain cancer	0.000386	0.00651	CcSEcCtD
Carbinoxamine—Decreased appetite—Hydroxyurea—brain cancer	0.000381	0.00643	CcSEcCtD
Carbinoxamine—Fatigue—Hydroxyurea—brain cancer	0.000378	0.00638	CcSEcCtD
Carbinoxamine—Vertigo—Temozolomide—brain cancer	0.000377	0.00636	CcSEcCtD
Carbinoxamine—Convulsion—Carmustine—brain cancer	0.000376	0.00635	CcSEcCtD
Carbinoxamine—Constipation—Hydroxyurea—brain cancer	0.000375	0.00632	CcSEcCtD
Carbinoxamine—Dizziness—Procarbazine—brain cancer	0.000375	0.00632	CcSEcCtD
Carbinoxamine—Palpitations—Temozolomide—brain cancer	0.000371	0.00626	CcSEcCtD
Carbinoxamine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00037	0.0109	CbGpPWpGaD
Carbinoxamine—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000365	0.0108	CbGpPWpGaD
Carbinoxamine—Convulsion—Temozolomide—brain cancer	0.000364	0.00613	CcSEcCtD
Carbinoxamine—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000363	0.0107	CbGpPWpGaD
Carbinoxamine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000362	0.0107	CbGpPWpGaD
Carbinoxamine—Feeling abnormal—Hydroxyurea—brain cancer	0.000361	0.00609	CcSEcCtD
Carbinoxamine—Vomiting—Procarbazine—brain cancer	0.00036	0.00608	CcSEcCtD
Carbinoxamine—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000358	0.0106	CbGpPWpGaD
Carbinoxamine—Confusional state—Carmustine—brain cancer	0.000357	0.00603	CcSEcCtD
Carbinoxamine—Headache—Procarbazine—brain cancer	0.000355	0.00599	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Carmustine—brain cancer	0.000347	0.00585	CcSEcCtD
Carbinoxamine—Chills—Etoposide—brain cancer	0.000346	0.00584	CcSEcCtD
Carbinoxamine—Tachycardia—Carmustine—brain cancer	0.000346	0.00583	CcSEcCtD
Carbinoxamine—Confusional state—Temozolomide—brain cancer	0.000345	0.00583	CcSEcCtD
Carbinoxamine—Anorexia—Carmustine—brain cancer	0.000338	0.0057	CcSEcCtD
Carbinoxamine—Nausea—Procarbazine—brain cancer	0.000337	0.00568	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Temozolomide—brain cancer	0.000335	0.00566	CcSEcCtD
Carbinoxamine—Hypotension—Carmustine—brain cancer	0.000331	0.00559	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Temozolomide—brain cancer	0.000331	0.00559	CcSEcCtD
Carbinoxamine—Anorexia—Temozolomide—brain cancer	0.000327	0.00551	CcSEcCtD
Carbinoxamine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000324	0.00957	CbGpPWpGaD
Carbinoxamine—Insomnia—Carmustine—brain cancer	0.000321	0.00541	CcSEcCtD
Carbinoxamine—Paraesthesia—Carmustine—brain cancer	0.000318	0.00537	CcSEcCtD
Carbinoxamine—Somnolence—Carmustine—brain cancer	0.000315	0.00531	CcSEcCtD
Carbinoxamine—Asthenia—Hydroxyurea—brain cancer	0.000315	0.00531	CcSEcCtD
Carbinoxamine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000313	0.00926	CbGpPWpGaD
Carbinoxamine—Insomnia—Temozolomide—brain cancer	0.00031	0.00523	CcSEcCtD
Carbinoxamine—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000309	0.00914	CbGpPWpGaD
Carbinoxamine—Decreased appetite—Carmustine—brain cancer	0.000308	0.0052	CcSEcCtD
Carbinoxamine—Paraesthesia—Temozolomide—brain cancer	0.000308	0.00519	CcSEcCtD
Carbinoxamine—Somnolence—Temozolomide—brain cancer	0.000305	0.00514	CcSEcCtD
Carbinoxamine—Constipation—Carmustine—brain cancer	0.000303	0.00511	CcSEcCtD
Carbinoxamine—Vertigo—Etoposide—brain cancer	0.000302	0.00509	CcSEcCtD
Carbinoxamine—Dyspepsia—Temozolomide—brain cancer	0.000302	0.00509	CcSEcCtD
Carbinoxamine—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.0003	0.00887	CbGpPWpGaD
Carbinoxamine—Diarrhoea—Hydroxyurea—brain cancer	0.0003	0.00506	CcSEcCtD
Carbinoxamine—Decreased appetite—Temozolomide—brain cancer	0.000298	0.00502	CcSEcCtD
Carbinoxamine—Fatigue—Temozolomide—brain cancer	0.000295	0.00498	CcSEcCtD
Carbinoxamine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000294	0.00869	CbGpPWpGaD
Carbinoxamine—Constipation—Temozolomide—brain cancer	0.000293	0.00494	CcSEcCtD
Carbinoxamine—Feeling abnormal—Carmustine—brain cancer	0.000292	0.00493	CcSEcCtD
Carbinoxamine—Convulsion—Etoposide—brain cancer	0.000291	0.00491	CcSEcCtD
Carbinoxamine—Dizziness—Hydroxyurea—brain cancer	0.00029	0.00489	CcSEcCtD
Carbinoxamine—Feeling abnormal—Temozolomide—brain cancer	0.000282	0.00476	CcSEcCtD
Carbinoxamine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00028	0.00827	CbGpPWpGaD
Carbinoxamine—Vomiting—Hydroxyurea—brain cancer	0.000279	0.0047	CcSEcCtD
Carbinoxamine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000278	0.00822	CbGpPWpGaD
Carbinoxamine—Confusional state—Etoposide—brain cancer	0.000276	0.00466	CcSEcCtD
Carbinoxamine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000276	0.00816	CbGpPWpGaD
Carbinoxamine—Headache—Hydroxyurea—brain cancer	0.000275	0.00463	CcSEcCtD
Carbinoxamine—Urticaria—Temozolomide—brain cancer	0.000272	0.00459	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Etoposide—brain cancer	0.000268	0.00453	CcSEcCtD
Carbinoxamine—Tachycardia—Etoposide—brain cancer	0.000268	0.00451	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Etoposide—brain cancer	0.000265	0.00447	CcSEcCtD
Carbinoxamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000265	0.00783	CbGpPWpGaD
Carbinoxamine—Anorexia—Etoposide—brain cancer	0.000261	0.00441	CcSEcCtD
Carbinoxamine—Nausea—Hydroxyurea—brain cancer	0.00026	0.00439	CcSEcCtD
Carbinoxamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000257	0.0076	CbGpPWpGaD
Carbinoxamine—Hypotension—Etoposide—brain cancer	0.000256	0.00432	CcSEcCtD
Carbinoxamine—Asthenia—Carmustine—brain cancer	0.000254	0.00429	CcSEcCtD
Carbinoxamine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000254	0.00751	CbGpPWpGaD
Carbinoxamine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000254	0.00751	CbGpPWpGaD
Carbinoxamine—Paraesthesia—Etoposide—brain cancer	0.000246	0.00415	CcSEcCtD
Carbinoxamine—Asthenia—Temozolomide—brain cancer	0.000246	0.00415	CcSEcCtD
Carbinoxamine—Somnolence—Etoposide—brain cancer	0.000244	0.00411	CcSEcCtD
Carbinoxamine—Diarrhoea—Carmustine—brain cancer	0.000243	0.00409	CcSEcCtD
Carbinoxamine—Decreased appetite—Etoposide—brain cancer	0.000238	0.00402	CcSEcCtD
Carbinoxamine—Fatigue—Etoposide—brain cancer	0.000236	0.00399	CcSEcCtD
Carbinoxamine—Dizziness—Carmustine—brain cancer	0.000234	0.00395	CcSEcCtD
Carbinoxamine—Constipation—Etoposide—brain cancer	0.000234	0.00395	CcSEcCtD
Carbinoxamine—Diarrhoea—Temozolomide—brain cancer	0.000234	0.00395	CcSEcCtD
Carbinoxamine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000227	0.0067	CbGpPWpGaD
Carbinoxamine—Dizziness—Temozolomide—brain cancer	0.000227	0.00382	CcSEcCtD
Carbinoxamine—Feeling abnormal—Etoposide—brain cancer	0.000226	0.00381	CcSEcCtD
Carbinoxamine—Vomiting—Carmustine—brain cancer	0.000225	0.0038	CcSEcCtD
Carbinoxamine—Headache—Carmustine—brain cancer	0.000222	0.00375	CcSEcCtD
Carbinoxamine—Vomiting—Temozolomide—brain cancer	0.000218	0.00367	CcSEcCtD
Carbinoxamine—Urticaria—Etoposide—brain cancer	0.000218	0.00367	CcSEcCtD
Carbinoxamine—Headache—Temozolomide—brain cancer	0.000215	0.00362	CcSEcCtD
Carbinoxamine—Nausea—Carmustine—brain cancer	0.000211	0.00355	CcSEcCtD
Carbinoxamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000209	0.00617	CbGpPWpGaD
Carbinoxamine—Nausea—Temozolomide—brain cancer	0.000203	0.00343	CcSEcCtD
Carbinoxamine—Asthenia—Etoposide—brain cancer	0.000197	0.00332	CcSEcCtD
Carbinoxamine—Diarrhoea—Etoposide—brain cancer	0.000188	0.00316	CcSEcCtD
Carbinoxamine—Dizziness—Etoposide—brain cancer	0.000181	0.00306	CcSEcCtD
Carbinoxamine—Vomiting—Etoposide—brain cancer	0.000174	0.00294	CcSEcCtD
Carbinoxamine—Headache—Etoposide—brain cancer	0.000172	0.0029	CcSEcCtD
Carbinoxamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000168	0.00497	CbGpPWpGaD
Carbinoxamine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000166	0.00491	CbGpPWpGaD
Carbinoxamine—Nausea—Etoposide—brain cancer	0.000163	0.00275	CcSEcCtD
Carbinoxamine—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000159	0.00471	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000157	0.00465	CbGpPWpGaD
Carbinoxamine—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000156	0.00461	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000154	0.00455	CbGpPWpGaD
Carbinoxamine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000143	0.00422	CbGpPWpGaD
Carbinoxamine—HRH1—IL-4 Signaling Pathway—IRS2—brain cancer	0.000141	0.00418	CbGpPWpGaD
Carbinoxamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000136	0.00403	CbGpPWpGaD
Carbinoxamine—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000135	0.00399	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000133	0.00393	CbGpPWpGaD
Carbinoxamine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000127	0.00375	CbGpPWpGaD
Carbinoxamine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.00012	0.00356	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000119	0.00351	CbGpPWpGaD
Carbinoxamine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000111	0.00327	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000109	0.00323	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—PTCH2—brain cancer	9.87e-05	0.00292	CbGpPWpGaD
Carbinoxamine—HRH1—IL-4 Signaling Pathway—RELA—brain cancer	9.76e-05	0.00289	CbGpPWpGaD
Carbinoxamine—HRH1—G alpha (q) signalling events—TRPC6—brain cancer	9.72e-05	0.00287	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	8.69e-05	0.00257	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—OR14C36—brain cancer	8.65e-05	0.00256	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—OR4C12—brain cancer	8.65e-05	0.00256	CbGpPWpGaD
Carbinoxamine—Brompheniramine—CYP2C9—brain cancer	8.43e-05	0.6	CrCbGaD
Carbinoxamine—HRH1—Signaling by GPCR—OR14C36—brain cancer	7.86e-05	0.00232	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—OR4C12—brain cancer	7.86e-05	0.00232	CbGpPWpGaD
Carbinoxamine—HRH1—IL-4 Signaling Pathway—STAT3—brain cancer	7.4e-05	0.00219	CbGpPWpGaD
Carbinoxamine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	7.24e-05	0.00214	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	7.14e-05	0.00211	CbGpPWpGaD
Carbinoxamine—Diphenhydramine—CYP2C9—brain cancer	5.61e-05	0.4	CrCbGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.18e-05	0.00153	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—SHH—brain cancer	5.08e-05	0.0015	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PTCH2—brain cancer	5.06e-05	0.0015	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—PTCH1—brain cancer	4.82e-05	0.00142	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR ligand binding—SMO—brain cancer	4.82e-05	0.00142	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—OR14C36—brain cancer	4.64e-05	0.00137	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—OR4C12—brain cancer	4.64e-05	0.00137	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.62e-05	0.00137	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—ABR—brain cancer	4.38e-05	0.00129	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—ABR—brain cancer	3.97e-05	0.00117	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—DTX2—brain cancer	3.95e-05	0.00117	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.79e-05	0.00112	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.38e-05	0.001	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.08e-05	0.000912	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PTCH2—brain cancer	2.99e-05	0.000884	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HES5—brain cancer	2.9e-05	0.000856	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—STRADA—brain cancer	2.81e-05	0.000831	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—TRPC6—brain cancer	2.77e-05	0.000819	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP2C9—brain cancer	2.73e-05	0.000806	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP2C9—brain cancer	2.67e-05	0.000789	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—SHH—brain cancer	2.61e-05	0.000771	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—TRPC6—brain cancer	2.52e-05	0.000744	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PTCH1—brain cancer	2.47e-05	0.000731	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—SMO—brain cancer	2.47e-05	0.000731	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ABR—brain cancer	2.35e-05	0.000694	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—BSG—brain cancer	2.32e-05	0.000685	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP2C9—brain cancer	2.31e-05	0.000682	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—BSG—brain cancer	2.27e-05	0.000671	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GLI2—brain cancer	2.27e-05	0.00067	CbGpPWpGaD
Carbinoxamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.23e-05	0.000658	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GLI1—brain cancer	2.13e-05	0.00063	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—VAV1—brain cancer	2.08e-05	0.000614	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP2C9—brain cancer	2.06e-05	0.000609	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SUFU—brain cancer	2.02e-05	0.000597	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—IDH1—brain cancer	1.99e-05	0.000589	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—BSG—brain cancer	1.96e-05	0.00058	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—IDH1—brain cancer	1.95e-05	0.000577	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GFAP—brain cancer	1.95e-05	0.000576	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.89e-05	0.00056	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—VAV1—brain cancer	1.88e-05	0.000557	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HEY1—brain cancer	1.85e-05	0.000546	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—DLL1—brain cancer	1.81e-05	0.000536	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—BSG—brain cancer	1.75e-05	0.000518	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—IDH1—brain cancer	1.69e-05	0.000499	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—BSG—brain cancer	1.61e-05	0.000476	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—BSG—brain cancer	1.6e-05	0.000472	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ENO2—brain cancer	1.58e-05	0.000466	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ENO2—brain cancer	1.54e-05	0.000456	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SHH—brain cancer	1.54e-05	0.000456	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—IDH1—brain cancer	1.51e-05	0.000445	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TRPC6—brain cancer	1.49e-05	0.000439	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PTCH1—brain cancer	1.46e-05	0.000432	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SMO—brain cancer	1.46e-05	0.000432	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—IDH1—brain cancer	1.39e-05	0.000409	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.37e-05	0.000406	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—IDH1—brain cancer	1.37e-05	0.000406	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ENO2—brain cancer	1.33e-05	0.000394	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	1.32e-05	0.00039	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.24e-05	0.000366	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.23e-05	0.000363	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CG—brain cancer	1.2e-05	0.000354	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ENO2—brain cancer	1.19e-05	0.000352	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOTCH2—brain cancer	1.17e-05	0.000345	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.12e-05	0.000331	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VAV1—brain cancer	1.11e-05	0.000329	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ENO2—brain cancer	1.09e-05	0.000324	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ENO2—brain cancer	1.09e-05	0.000321	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—BSG—brain cancer	1.05e-05	0.000311	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HES1—brain cancer	9.57e-06	0.000283	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—IL2—brain cancer	9.27e-06	0.000274	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PDGFRA—brain cancer	9.12e-06	0.00027	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—IDH1—brain cancer	9.06e-06	0.000268	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SPP1—brain cancer	8.85e-06	0.000262	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL2—brain cancer	8.42e-06	0.000249	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IRS2—brain cancer	8e-06	0.000237	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CG—brain cancer	7.23e-06	0.000214	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ENO2—brain cancer	7.16e-06	0.000212	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CG—brain cancer	7.08e-06	0.000209	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APC—brain cancer	7.07e-06	0.000209	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CG—brain cancer	7.07e-06	0.000209	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—EGFR—brain cancer	6.44e-06	0.00019	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CG—brain cancer	6.12e-06	0.000181	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RELA—brain cancer	5.52e-06	0.000163	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ERBB2—brain cancer	5.49e-06	0.000162	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CG—brain cancer	5.46e-06	0.000161	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CG—brain cancer	5.02e-06	0.000148	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.98e-06	0.000147	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL2—brain cancer	4.97e-06	0.000147	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCND1—brain cancer	4.85e-06	0.000143	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CTNNB1—brain cancer	4.8e-06	0.000142	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—brain cancer	4.23e-06	0.000125	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—STAT3—brain cancer	4.19e-06	0.000124	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MYC—brain cancer	3.89e-06	0.000115	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EGFR—brain cancer	3.8e-06	0.000112	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CG—brain cancer	3.28e-06	9.71e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TP53—brain cancer	3.19e-06	9.44e-05	CbGpPWpGaD
